Hematech Consultants SPRL
The score of Hematech Consultants shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -10 % Total assets -10 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Hematech Consultants's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 30 Apr 2026
- Year ended 30 Sep 2024filed on 01 Apr 2025
- Year ended 30 Sep 2023filed on 31 Mar 2024
- Year ended 30 Sep 2022filed on 27 Apr 2023
- Year ended 30 Sep 2021filed on 29 Apr 2022
Hematech Consultants's financial analysis
- Solvency99.4%sector median: 56.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Hematech Consultants
Hematech Consultants's publications in the Belgian Gazette
No Belgian Gazette publication known for this company.
Company number, VAT number and registered office
- Company number (CBE)
- 0444.295.137
- VAT number
- BE0444295137
- Peppol
- Registered · 0208:0444295137 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 27 May 1991
- Registered office
- 1540 Pajottegem
- Latest accounts
- 2025 · filed on 30 Apr 2026
- Activity
- Other tax services (NACE 69209)
Hematech Consultants (SPRL) has been based in Pajottegem since 1991, active in: other tax services. For 2025, it reports a net loss of 2,133 € and equity of 47,963 €; its revenue is not published. Its solvency stands at 99.4%, above the median of its sector (56.7%).
Companies similar to Hematech Consultants
Companies in the same business, of comparable size and area, outside its group.
- Fideos Comex Management Accounting, bookkeeping and auditing activities; tax consultancy Tubize · balance sheet 51,522 €
- Samuel DE Block-Boekhouding Fiscaliteit Accounting, bookkeeping and auditing activities; tax consultancy Ninove · balance sheet 52,780 €
- Biticompta Accounting, bookkeeping and auditing activities; tax consultancy Beersel · balance sheet 41,551 €
- FDG Consulting Accounting, bookkeeping and auditing activities; tax consultancy Tubize · balance sheet 39,573 €
- Corga Accounting, bookkeeping and auditing activities; tax consultancy Zaventem · balance sheet 49,992 €
- Euregio Adviesgroep Maaseik Accounting, bookkeeping and auditing activities; tax consultancy Lanaken · balance sheet 41,967 €
- Hendrickx Accounting, bookkeeping and auditing activities; tax consultancy Zoersel · balance sheet 56,848 €
- Bofimag Accounting, bookkeeping and auditing activities; tax consultancy Mortsel · balance sheet 58,656 €
Frequently asked questions about Hematech Consultants
What is the revenue of Hematech Consultants?
Hematech Consultants files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Hematech Consultants?
In Belgium, the VAT number is the company number prefixed with BE: BE0444295137 for Hematech Consultants, if the company is VAT-registered. Its company number (CBE) is 0444.295.137.
Where is the registered office of Hematech Consultants?
According to the CBE register, the registered office of Hematech Consultants is in 1540 Pajottegem.
What is the equity of Hematech Consultants?
At the close of the 2025 financial year, the equity of Hematech Consultants amounts to 47,963 €, a solvency of 99.4% of total assets.
Who manages Hematech Consultants?
The register lists 1 active mandates at Hematech Consultants. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Hematech Consultants
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →